Since its inception, the A-T Children’s Project has utilized a careful and detailed, two-tiered, peer-review selection process for making grant award decisions.

The first tier is composed of a group of all-voluntary scientific investigators and clinicians who review grant proposals and provide critical expert guidance. Their recommendations for funding are then reviewed by the A-TCP Board of Directors, who compose the second tier.

Our network of scientific advisors also share their expertise as the A-TCP continually works to refine our strategies to accelerate A-T research.

Characteristics that define our network of scientific and clinical advisors:

  • Smart (according to many other smart people!)
  • Multi-disciplinary
  • From both basic science as well as clinical practice
  • From academia and industry
  • Active in their areas of expertise
  • Not necessarily famous
  • Brutally candid
  • And, for the purposes of grant proposal review, cannot be receiving or seeking funds from us

We would like thank all of our advisors for sharing their valuable time with the A-TCP as it orchestrates and funds international research to accelerate progress against A-T. Meet just a few of the scientists who are part of our network of advisors:

Larry Gelbert, PhD

Adjunct Professor, Pediatrics Hematology/Oncology
Indiana University School of Medicine
Indianapolis, Indiana

Nathaniel Heintz, PhD

Investigator, Professor
Head of Laboratory of Molecular Biology
Howard Hughes Medical Institute
Rockefeller University
New York, New York

Eugene Johnson, PhD

Professor, Dept. of Neurology, Molecular Biology and Pharmacology
Washington University School of Medicine
St. Louis, Missouri

Rodney L. Levine, MD, PhD

Senior Investigator, Protein Function in Disease Section
National Heart, Lung and Blood Institute, NIH
Bethesda, Maryland

Jean Mariani, MD, PhD

Curie Institute
Paris, France

Theo Palmer, PhD

Associate Professor of Neurosurgery
Vice Chair of Neurosurgical Research
Stanford School of Medicine
Stanford, California

Gary Peltz, MD, PhD

Head of Genetics
Inflammatory Diseases Business Unit
Roche Bioscience
Palo Alto, California

Joshua R. Sanes, PhD

Professor, Department of Molecular and Cellular Biology
Director, Center for Brain Science
Harvard University
Cambridge, Massachusetts

Huda Y. Zoghbi, MD

Professor, Baylor College of Medicine
Investigator, Howard Hughes Medical Institute
Houston, Texas